Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Robert Lyle

Concepts (109)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ductus Arteriosus, Patent
2
2019
38
0.310
Why?
DNA
1
2010
542
0.280
Why?
Asthma
1
2010
279
0.270
Why?
Intensive Care Units, Neonatal
2
2018
116
0.270
Why?
Infant, Premature
4
2019
318
0.220
Why?
Medicaid
2
2018
255
0.200
Why?
Disabled Children
2
2013
63
0.190
Why?
Infant, Newborn
7
2019
2767
0.180
Why?
Hospitalization
2
2017
663
0.170
Why?
Persistent Fetal Circulation Syndrome
1
2019
9
0.160
Why?
Chronic Disease
3
2011
571
0.160
Why?
Health Care Costs
2
2018
169
0.160
Why?
Infant, Low Birth Weight
1
2018
62
0.150
Why?
Child, Preschool
7
2018
3877
0.150
Why?
Continuity of Patient Care
1
2018
52
0.150
Why?
Clinical Protocols
1
2017
108
0.140
Why?
Immunologic Deficiency Syndromes
1
2016
19
0.140
Why?
Hypoglycemia
1
2016
52
0.130
Why?
Infant, Premature, Diseases
1
2017
94
0.130
Why?
DNA Copy Number Variations
2
2016
110
0.130
Why?
Child
8
2018
6854
0.130
Why?
Developmental Disabilities
1
2016
119
0.130
Why?
Hospitals, Pediatric
3
2013
234
0.120
Why?
Emergency Service, Hospital
1
2018
483
0.110
Why?
Comprehensive Health Care
1
2013
9
0.110
Why?
Infant
6
2018
3560
0.110
Why?
Blood Cells
1
2012
43
0.100
Why?
Genome, Human
1
2012
111
0.100
Why?
Child, Exceptional
1
2011
5
0.090
Why?
Cost Savings
1
2011
58
0.090
Why?
Parents
1
2013
314
0.090
Why?
Follow-Up Studies
2
2018
2180
0.090
Why?
Fetal Blood
1
2010
69
0.090
Why?
Gene Expression Regulation, Developmental
1
2010
136
0.080
Why?
Longitudinal Studies
3
2018
687
0.080
Why?
Genetic Association Studies
1
2010
116
0.080
Why?
Ambulatory Care
1
2011
223
0.080
Why?
Patient Care Team
1
2011
258
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2013
486
0.080
Why?
Time Factors
2
2018
2911
0.080
Why?
Humans
13
2022
50251
0.080
Why?
Outpatient Clinics, Hospital
1
2009
35
0.080
Why?
Genotype
1
2010
533
0.080
Why?
Child Health Services
1
2009
76
0.080
Why?
Home Care Services
1
2009
72
0.070
Why?
Female
8
2018
26668
0.070
Why?
Polymorphism, Single Nucleotide
1
2010
486
0.070
Why?
Male
7
2018
25483
0.070
Why?
DNA Methylation
1
2010
550
0.060
Why?
Cohort Studies
3
2018
1397
0.060
Why?
Patient Discharge
2
2018
318
0.060
Why?
Prospective Studies
1
2010
2379
0.060
Why?
Embryonic Stem Cells
1
2022
15
0.050
Why?
Cell Differentiation
2
2022
652
0.050
Why?
Age Factors
2
2018
1088
0.050
Why?
Adolescent
3
2018
6402
0.050
Why?
Peptide Hydrolases
1
2002
62
0.050
Why?
Acetylcysteine
1
2002
103
0.050
Why?
Phosphoproteins
1
2002
108
0.050
Why?
Proteasome Endopeptidase Complex
1
2002
117
0.050
Why?
Arkansas
3
2013
1962
0.050
Why?
Adipocytes
1
2002
121
0.050
Why?
Cell Survival
1
2022
602
0.050
Why?
Neurons
1
2022
459
0.040
Why?
Proteins
1
2002
345
0.040
Why?
Time
1
2018
25
0.040
Why?
Ibuprofen
1
2018
21
0.040
Why?
Indomethacin
1
2018
38
0.040
Why?
United States
3
2018
4887
0.040
Why?
Cyclooxygenase Inhibitors
1
2018
39
0.040
Why?
Birth Weight
1
2019
120
0.040
Why?
Infant, Newborn, Diseases
1
2016
57
0.030
Why?
Patient Readmission
1
2018
218
0.030
Why?
Incidence
1
2018
986
0.030
Why?
Logistic Models
1
2018
891
0.030
Why?
High-Throughput Nucleotide Sequencing
1
2016
171
0.030
Why?
Databases, Factual
1
2018
655
0.030
Why?
Young Adult
2
2016
4002
0.030
Why?
Length of Stay
1
2018
627
0.030
Why?
Genomics
1
2016
287
0.030
Why?
Blood Glucose
1
2016
435
0.030
Why?
Risk Assessment
1
2018
1257
0.030
Why?
Health Care Surveys
1
2013
173
0.030
Why?
Twins, Monozygotic
1
2012
17
0.030
Why?
Individuality
1
2012
30
0.020
Why?
Patient-Centered Care
1
2013
129
0.020
Why?
Myelodysplastic Syndromes
1
2012
81
0.020
Why?
Aged
2
2016
9427
0.020
Why?
Cerebral Palsy
1
2010
40
0.020
Why?
Cost-Benefit Analysis
1
2011
271
0.020
Why?
Bronchopulmonary Dysplasia
1
2010
71
0.020
Why?
Multivariate Analysis
1
2011
578
0.020
Why?
Middle Aged
2
2016
12234
0.020
Why?
Adult
2
2016
13384
0.020
Why?
Quality of Life
1
2013
837
0.020
Why?
Program Evaluation
1
2009
352
0.020
Why?
Rural Population
1
2011
541
0.020
Why?
Mutation
1
2012
1296
0.020
Why?
Retrospective Studies
1
2018
6172
0.020
Why?
Aged, 80 and over
1
2012
3140
0.010
Why?
Treatment Outcome
1
2013
5186
0.010
Why?
Leupeptins
1
2002
7
0.010
Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
Why?
Cysteine Proteinase Inhibitors
1
2002
22
0.010
Why?
Calpain
1
2002
25
0.010
Why?
Kinetics
1
2002
632
0.010
Why?
Nuclear Proteins
1
2002
243
0.010
Why?
Cell Line
1
2002
1024
0.010
Why?
Animals
1
2002
13285
0.000
Why?
Lyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description